Page 71 - 中国全科医学2022-21
P. 71
·2628· http://www.chinagp.net E-mail:zgqkyx@chinagp.net.cn
因子影响,本研究显示 R 与 APTT 呈弱正相关。K、α [7]NARITA M. Classification of extrapulmonary manifestations due
角主要与 FIB 及部分血小板功能有关,本研究显示 K、 to Mycoplasma pneumoniae infection on the basis of possible
pathogenesis[J]. Front Microbiol,2016,7:23. DOI:
α 角与 FIB、PLT 有弱相关性。CI 是对整个凝血过程进
10.3389/fmicb.2016.00023.
行评价的综合指标,本研究显示其与 D-D 有弱相关性。
[8]KALICKI B,SADECKA M,WAWRZYNIAK A,et al. Absence
总体而言,在 MPP 患儿中 TEG 参数与常规凝血参数的 of inferior vena cava in 14-year old boy associated with deep venous
相关性并不高,可能与临床上常规凝血主要检测凝血过 thrombosis and positive Mycoplasma pneumoniae serum antibodies—a
程中的一个孤立部分,而 TEG 检测凝血、纤溶整个过 case report[J]. BMC Pediatr,2015,15:40.
程有关,提示两者在 MPP 患儿凝血功能及病情评估中 [9]WITMER C M,STEENHOFF A P,SHAH S S,et al. Mycoplasma
pneumoniae,splenic infarct,and transient antiphospholipid
不能相互替代。
antibodies:a new association? [J]. Pediatrics,2007,119(1):
多因素 Logistic 回归分析结果显示,CI、D-D 均
e292-295. DOI:10.1542/peds.2006-1340.
为 MPP 患儿病情的影响因素,ROC 曲线分析提示 AUC [10]MÜLLER-CALLEJA N,HOLLERBACH A,RITTER S,et al.
CI+D-D>CI>D-D,AUC 可反应各指标预测 MPP 患儿病 Tissue factor pathway inhibitor primes monocytes for antiphospholipid
情的准确性,一般认为 AUC 为 0.5~0.7 时预测准确性较 antibody-induced thrombosis[J]. Blood,2019,134(14):
低,0.7~0.9 时预测准确性中等,大于 0.9 时预测准确 1119-1131. DOI:10.1182/blood.2019001530.
[11]CHRYSSANTHOPOULOS C,EBORIADOU M,MONTI K,et al.
性较高。本研究显示 CI、D-D 的 AUC 均在 0.7~0.9 之
Fatal disseminated intravascular coagulation caused by Mycoplasma
间, 且 CI>D-D、CI+D-D 的 AUC 大 于 0.9, 提 示 TEG
pneumoniae[J]. Pediatr Infect Dis J,2001,20(6):634-
及常规凝血参数对MPP患儿病情均有中等预测准确性, 635. DOI:10.1097/00006454-200106000-00021.
TEG 的预测准确性高于常规凝血参数,两者联合后预测 [12]PACHET A,DUMESTRE-PERARD C,MOINE M,et al. Splenic
准确性最佳。 infarction associated with transient anti-prothrombin antibodies is a
综上所述:临床上可根据 TEG、常规凝血参数来预 rare manifestation of acute Mycoplasma pneumoniae infection[J].
Arch Pediatr,2019,26(8):483-486. DOI:10.1016/j.
测 MPP 患儿的病情,TEG 的预测准确性更高,但 TEG
arcped.2019.10.001.
不能取代常规凝血参数,两者联合后预测准确性最佳。 [13]NARITA M. Pathogenesis of extrapulmonary manifestations
作者贡献:桂晶晶进行文章的构思与设计,撰写论 of Mycoplasma pneumoniae infection with special reference to
文;金阿全、万瑜进行研究的实施与可行性分析,数据 pneumonia[J]. J Infect Chemother,2010,16(3):162-169.
收集;赵轩、朱琳杰进行数据整理,统计学分析;赵逸 DOI:10.1007/s10156-010-0044-x.
东、姚嘉琦、张力文进行结果的分析与解释,论文的修 [14]PODDIGHE D. Mycoplasma pneumoniae-related hepatitis in
children[J]. Microb Pathog,2020,139:103863. DOI:
订;黄志英进行英文的修订,负责文章的质量控制及审
10.1016/j.micpath.2019.103863.
校,对文章整体负责,监督管理。
[15]何婧瑜,王晶 . 成人支原体肺炎患者凝血功能变化及其与外周
本文无利益冲突。 血单核细胞百分比的相关性[J]. 中国急救医学,2021,41(3):
参考文献 191-195. DOI:10.3969/j.issn.1002-1949.2021.03.002.
[1]XING Y,WANG D,SHENG K,et al. Dynamic change of [16]韩利,张筠,张铁栓 . 重症肺炎患者 D- 二聚体、纤维蛋白原、
Mycoplasma pneumoniae pneumonia in hospitalized children in IL-6 水平变化及其临床意义[J]. 中国呼吸与危重监护杂志,
a general hospital:a 3-year retrospective analysis[J]. Transl 2017,16(1):71-73.
Pediatr,2020,9(4):522-531. DOI:10.21037/tp-20-149. [17]ZHENG Y,HUA L L,ZHAO Q N,et al. The level of D-dimer
[2]GAO L W,YIN J,HU Y H,et al. The epidemiology of is positively correlated with the severity of Mycoplasma pneumoniae
paediatric Mycoplasma pneumoniae pneumonia in North China: pneumonia in children[J]. Front Cell Infect Microbiol,2021,
2006 to 2016[J]. Epidemiol Infect,2019,147:e192. DOI: 11:687391. DOI:10.3389/fcimb.2021.687391.
10.1017/S0950268819000839. [18]HUANG X,LI D,LIU F,et al. Clinical significance of D-dimer
[3]LIU J W,LI Y M. Thrombosis associated with Mycoplasma levels in refractory Mycoplasma pneumoniae pneumonia[J]. BMC
pneumoniae infection(Review)[J]. Exp Ther Med,2021,22(3): Infect Dis,2021,21(1):14. DOI:10.1186/s12879-020-
967. DOI:10.3892/etm.2021.10399. 05700-5.
[4]江载芳,申昆玲,沈颖 . 诸福棠实用儿科学[M]. 8 版 . 北京: [19]RAMADORI G. Albumin infusion in critically ill COVID-19
人民卫生出版社,2015:1282-1284. patients:hemodilution and anticoagulation[J]. Int J Mol Sci,
[5]中华人民共和国国家健康委员会,国家中医药局 . 儿童 2021,22(13):7126. DOI:10.3390/ijms22137126.
社区获得性肺炎诊疗规范(2019 年版)[J]. 中华临床 [20]BRUBAKER L,MORTUS J,CRUZ M,et al. Thromboelastography
感 染 病 杂 志,2019,12(1):6-13. DOI:10.3760/cma. might be more applicable to guide anticoagulant therapy than
j.issn.1674-2397.2019.01.002. fibrinolytic therapy in critically ill patients with COVID-19[J].
[6]LIU J R,HE R X,WU R H,et al. Mycoplasma pneumoniae J Am Coll Surg,2021,232(6):1021-1022. DOI:10.1016/j.
pneumonia associated thrombosis at Beijing Children's Hospital[J]. jamcollsurg.2021.03.005.
BMC Infect Dis,2020,20(1):51. DOI:10.1186/s12879-020- (收稿日期:2022-02-08;修回日期:2022-02-21)
4774-9. (本文编辑:程圣)